Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen) by unknown
FUNCTIONAL  PROPERTIES  OF  A  UNIQUE  SUBSET  OF 
CYTOTOXIC  CD3 +  T  LYMPHOCYTES  THAT  EXPRESS  Fc 
RECEPTORS  FOR  IgG  (CD16/LEU-1 1  ANTIGEN) 
BY  LEWIS L. LANIER,*  THOMAS J. KIPPS,*  AND JOSEPH  H.  PHILLIPS* 
From the *Becton Dickinson Monoclonal  Center, Inc., Mountain View, California 94043; and 
the *Stanford University School of Medicine, Department of Genetics, 
Stanford,  California 94305 
Human T  lymphocytes were initially identified (1) and distinguished from B 
lymphocytes based  on  the ability of T  cells to form spontaneous rosettes with 
sheep erythrocytes (E). 1 Within the E + subset, Moretta et al. (2) defined a discrete 
subpopulation of cells that bound IgG-coated erythrocytes (EA) via a specific cell 
surface receptor for the Fc region of IgG (FcR). This population was designated 
the T~, subset. These cells have been shown to mediate suppressor cell function 
(2), antibody-dependent cellular cytotoxicity (ADCC) (3), and natural killer (NK) 
cell-mediated cytotoxicity (4, 5). 
Using  monoclonal  antibodies  (mAb)  against  human  T  cell  differentiation 
antigens, two antigenically and functionally distinct subsets of E + cells have been 
identified. The  majority of E + lymphocytes express  the pan-T  cell-associated 
antigens,  CD3  and  CD5;  whereas a  minor subset of E + cells lack CD3  (5-7). 
However, most IgG-FcR  + cells are contained within this small CD3- fraction (5- 
7). NK cell-mediated cytotoxicity is confined to E + lymphocytes lacking the CD3 
antigen (5). Based on these findings, it was unclear whether functions attributed 
to the T7  subset were mediated by the CD3-  (non-T)  NK cell fraction or the 
very small proportion of CD3 + T  cells that express FcR for IgG. 
Recently, several  mAb  (anti-Leu-ll,  VEP  13,  B73.1,  and  3G8)  have  been 
produced (8-12) that specifically react with the IgG FcR expressed on NK cells 
and neutrophils. These antibodies do not react with the IgG FcR expressed on 
monocytes or B lymphocytes (8-10,  12). Essentially all NK and ADCC function 
is contained within the small fraction of lymphocytes that express this IgG FcR 
(i.e. CD16/Leu-1 1 antigen) (8-10,  12,  13). 
We (8,  12) and other investigators (9-1 1) reported that these anti-FcR anti- 
bodies did not react with a significant proportion of CD3 + T  lymphocytes isolated 
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from peripheral blood, concanavalin A-activated cultures, or mixed lymphocyte 
response  cultures.  However,  several  patients  with  T  cell  lymphoproliferative 
disorders have been shown (14-17) to coexpress both CD3 antigen and IgG FcR. 
This finding prompted us to investigate whether or not any CD3 ÷ T  lymphocytes 
obtained from normal individuals express the IgG FcR detected by the anti-Leu- 
11  mAb.  In this report, we show that a  functionally unique subset of cytotoxic 
T  lymphocytes in peripheral blood can be identified by coexpression of the CD3 
and CD16 (Leu-11) antigens. 
Materials and Methods 
Preparation of  Human Peripheral Blood Leukocytes (PBL).  Human peripheral blood from 
random,  normal  donors  was  obtained  from  volunteer  donors  at  our  institutes,  the 
American  Red  Cross (San Jose,  CA)  or the  Stanford Blood Center (Palo Alto,  CA). 
Mononuclear cells were isolated using Ficoll/Hypaque. In sorting experiments, monocytes 
and B cells were depleted by plastic adherence and nylon wool columns, as described (18). 
Antibodies.  All Leu series mAb were prepared at the Becton Dickinson Monoclonal 
Center. Anti-Tac (interleukin 2 receptor [IL-2-R]) antibody was provided by T. Wald- 
mann,  National Institutes of Health, Bethesda, MD (19).  Anti-Leu-1, anti-Leu-2a, anti- 
Leu-3a, anti-Leu-4, and anti-Leu-5b (E rosette receptor) recognize the CD5, CD8, CD4, 
CD3, and CD2 T cell differentiation antigens, respectively. Anti-Leu-1 la (IgG1 antibody), 
anti-Leu-1 lb  (IgM  antibody) and  anti-Leu-1 lc  (IgG1  antibody that  binds  a  different 
epitope than anti-Leu-1 la and -b) recognize the IgG FcR (CD16) present on essentially 
all  NK cells  and neutrophils (12).  Anti-Leu-15 detects an epitope on the complement 
receptor type 3, CR3 (CD11) (20).  Anti-Leu-M3 recognizes an antigen expressed exclu- 
sively on monocytes. Anti-Leu-7 reacts with an antigen present on a subset of NK cells 
and T lymphocytes (8, 21). Anti-Leu-12 detects the CD 19 antigen, expressed on essentially 
all B lymphocytes. 
Isotype switch-variant antibodies of ME I or MA2.1 were used to detect ADCC activity 
(13). The ME1 antibody reacts with HLA-B7, Bw22, Bw42, and B27, whereas the MA2.1 
antibody reacts with HLA-A2. 
FcR were detected using covalently linked dimeric rabbit IgG and fluorescein isothio- 
cyanate (FITC)-conjugated F(ab')~  goat anti-rabbit IgG, provided by J. Titus (NIH) (22, 
23). 
F(ab')2 fragments of anti-Leu-1 la and anti-Leu-4 antibodies (both IgG1 isotype) were 
prepared by pepsin digestion (Worthington Biochemicals, Freehold, NJ) (25 #g pepsin 
per milligram IgG, pH 4.0, 5 h, 37°C) as described by Parham (24). The F(ab')~ fragments 
were purified by size-exclusion high-pressure liquid chromatography. Fragments  were 
analyzed for purity by sodium dodecyl sulfate-polyacrylamide gel electrophoresis using 
Coomassie Brilliant Blue R-250 dye for visualization of proteins (25).  Antibodies were 
conjugated with FITC (Molecular Probes, Beaverton, OR) or N-hydroxysuccinimidobiotin 
(Pierce Chemical Co.,  Rockford, IL) as described by Goding (26).  All antibodies were 
titrated for specific binding activity by direct or indirect immunofluorescence. The titers 
of the F(ab')2 antibodies were equivalent to the intact molecules. 
Immunofluorescence  and Flow Cytometry.  Methods of immunofluorescence, flow cytom- 
etry, and data analysis have been presented elsewhere (8, 27, 28).  Fluorochrome-conju- 
gated, isotype-matched mAb that do not react with human cells were used to control for 
nonspecific binding in the immunofluorescence assays.  For quantitation of fluorescence, 
the  variable  logarithmic amplifiers were calibrated to span  four log decades.  On  the 
fluorescence histograms, the abscissa  was arbitrarily divided into 256 channels, with 64 
channels representing a 10-fold increase in fluorescence. By determining the mean channel 
of a population and converting this number from a logarithmic to a linear value, it was 
possible to compare the relative amounts of fluorescence of different populations. 
Tumor Cells.  All  tumor cell lines  were obtained from the American  Type Culture LANIER  ET  AL.  2091 
Collection,  Rockville, MD, and were tested monthly to insure against  mycoplasma infec- 
tion. 
Cytotoxicity Assays.  For NK cytotoxicity assays, 5~Cr-labeled K562 cells were used as 
targets  in  a  4-h  radioisotope-release  assay,  as  described  (8,  29).  ADCC  assays were 
performed using the relatively  NK-insensitive B lymphoblastoid cell line JY, as described 
(13). JY expresses HLA antigens A2 and B7. 
Proliferation Assays.  Lymphocytes were cocultured with mitomycin  C-treated tumor 
cell lines as described (30). Proliferation was measured by incorporation of [~H]thymidine 
(30). Lectin-free, purified IL-2 was purchased from Electronucleonics,  Inc. (Silver Spring, 
MD). For short term growth, cells were cultured in RPMI-1640 (Irvine Scientific, Santa 
Ana,  CA)  supplemented  with  I0%  heat-inactivated  fetal  calf serum  (KC  Biologicals, 
Lexena, KS), 1 mM glutamine (Gibco, Grand Island,  NY), antibiotics,  and  10% purified 
IL-2. 
Morphology.  Giemsa-stained  specimens were prepared as described (29). 
Results 
Coexpression of CD3 and IgG-FcR (CD16/Leu-11 Antigen) on PBL.  In a routine 
phenotypic analysis of the  PBL obtained  from  normal,  healthy donors at  our 
institute,  we  observed  two  individuals  (D.  H.  and  L.  G.)  who  possessed  a 
significant  proportion  of iymphocytes coexpressing  CD3  and  CD16  (Leu-11) 
antigens. As shown in Fig.  1, 23.6% of D. H.'s lymphocytes and 9.4% of L. G.'s 
lymphocytes were CD3+,CD16÷;  whereas 46.6%  (D.  H.) and  61.0%  (L.  G.) of 
lymphocytes were typical T  iymphocytes with the phenotype CD3+,CD16-. The 
proportion  of CD3-,CD16 +  NK  cells  was  within  the  normal  range  for  both 
individuals (18.0%, D. H.; 14.0%, L. G.). Peripheral blood from both L. G. and 
D. H. have been sequentially monitored over the past 6 and 18 mo, respectively, 
with  no significant  change  in  the  proportion  of CD3+,CD16 + lymphocytes or 
absolute lymphocyte number. 
The  specificity of antibody binding  was established by the  findings  that:  (a) 
An equal percentage of CD3  ÷ cells were costained with both IgM (anti-Leu-1 lb) 
and IgGl (anti-Leu-1 la) mAb against a common epitope on the IgG-FcR. Neither 
control IgM nor IgG1  mAb reacted with a subset oft  lymphocytes (Fig.  1). (b) 
Coexpression of CD 16 and CD3 antigens was also demonstrated using the anti- 
Leu- 11 c/B73.1  (Fig. 4) and OKT3 antibodies (not shown). Anti-Leu- 11 c/B73.1 
reacts with a different epitope on the Fc-IgG receptor that does not inhibit the 
binding of the anti-Leu-1 l a and -b antibodies (12).  (c) Two-color immunofluo- 
rescence using F(ab')2 fragments of anti-Leu-4 and anti-Leu-1 la confirmed that 
a subset of CD3 ÷ T  lymphocytes coexpressed the CD16 antigen (Fig. 2). 
FcR-bearing  CD3 + T  cells could be distinguished  by the  levels of FcR and 
CD3  surface  antigen  expression  compared  to  other  cell  types.  The  apparent 
density of CD16 antigen on the CD3 + T  lymphocytes was significantly less than 
on  the  CD3-  subset.  Moreover,  the  apparent  amount  of  CD3  antigen  was 
significantly higher  on the CD3+,CD16 ÷ compared with the CD3+,CD16 -  cells 
(Figs.  1 and 2).  In an independent experiment, the amount of fluorescence was 
quantitated  by determining  the  mean  fluorescence value  for  each  population 
(Fig.  3).  The  upper panels display the fluorescence histograms  for FITC-anti- 
Leu-11 a and phycoerythrin (PE) anti-Leu-4 binding to L. G.'s lymphocytes. Note 
that the anti-Leu-11-stained  cells show three distinct populations: an unstained 
population, ceils with low density (dim) CD16 antigen  (11.6% of lymphocytes), 2092  FUNCTIONAL  PROPERTIES  OF  Fc  RECEPTOR-BEARING  T  CELLS 
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FIGURE  1.  Coexpression of CD3 and CD16 on normal PBL. Peripheral blood mononuclear 
cells from two individuals (D. H. ]upper panels] and L. G. ]lower panels]) were stained with 
fluorochrome-conjugated control antibodies (lej~); FITC-anti-Leu-1 la (IgG1  antibody) and 
PE-anti-Leu-4 (middle);  and  FITC-anti-Leu-1 lb (IgM antibody) and  PE-anti-Leu-4 (right). 
Lymphocytes were distinguished from monocytes on the basis of their characteristic 90 ° and 
forward angle light scatter profiles. Correlated green (abscissa,  four-decade log scale) and red 
(ordinate,  four-decade log scale) fluorescence of the lymphocytes are displayed as contour 
plots. Based on the Ig control sample, the contour plots were divided into quadrants:  I, cells 
with red fluorescence only; II, cells with red and green fluorescence; III, unstained cells; and 
IV,  cells  with  green  fluorescence  only.  The  number  of  cells  within  each  quadrant  was 
determined and the percentage of the total number of lymphocytes calculated. Analysis of D. 
H.'s  lymphocytes  indicated:  46.6%  CD3÷,CD16-;  23.6%  CD3+,CD16÷;  and  18.1%  CD3- 
,CD16  +.  For  L.  G.'s  lymphocytes,  61.0%  CD3+,CD16-;  9.4%  CD3+,CD16+;  and  14.0% 
CD3-,CD16 +.  In  the  control  contour  plots,  >98%  of lymphocytes  were  in  quadrant  III 
(unstained). 
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FIGURE 2.  Two-color immunofluorescence using F(ab')~ fragments of anti-Leu-11 and anti- 
Leu-4. Nonadherent PBL from D. H. were stained with FITC-conjugated F(ab')~ anti-Leu-4 
and biotin-conjugated F(ab')= anti-Leu-1 la mAb (B) or appropriate  control IgG antibodies 
(A).  PE-conjugated streptavidin  was  used to detect binding of biotin-conjugated antibodies. 
Data are presented as described in Fig. 1. 
and cells with high density (bright) CD 16 antigen  (13.2%).  As shown previously 
(8,  12, 31), this dim CD 16 + subset is absent from most normal individuals.  Gates 
were  set  on  these  three  distinct  subsets,  and  the  PE-anti-Leu-4  staining  was LANIER  ET  AL. 
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FIGURE  3.  Quantitation of CD3 and CD16 antigen expression. Peripheral blood mononu- 
clear cells (L. G.) were stained with: FITC-lgG1 and PE-IgG1 control antibodies, or FITC- 
anti-Leu- 11 a and PE-anti-Leu-4 antibodies. Data were collected in list-mode files and displayed 
as histograms (abscissa, 256 channels, four-decade log scale; ordinate, relative number of cells). 
In A and B, the fluorescence from the stained sample (solid line) is superimposed over the 
fluorescence of the control sample (broken line). The percentage of stained cells and relative 
amount of fluorescence (indicated in the parenthesis as arbitary linear fluorescence units) are 
shown. Note that in A there are three distinct populations of cells in the anti-Leu-1 la-stained 
sample: unstained, dim CD16 ÷ (11.6%), and bright CD16 ÷ (13.2%) cells. In C, E, and G, a 
gate  was  placed  on  each  of these  subpopulations and  the  anti-Leu-4  staining profile  was 
displayed  for  the  selected population.  The  ordinate was  rescaled  in  each panel to  permit 
optimal visualization of the results. 
displayed for each population. Within the dim CD16 + cells, 82.9% expressed the 
CD3 antigen.  In  contrast,  only 2%  of the bright  CD16 + cells expressed CD3. 
Quantitative comparison of the populations indicated that the dim CD16 + cells 
expressed ~10% of the CD16 antigen compared to the bright CD16 + cells. The 
dim CDI6 ÷ cells were also unique in that they showed about twice as much CD3 
antigen as the typical CD3+,CD16- T  lymphocytes (Fig. 3). Quantitative studies 2094  FUNCTIONAL PROPERTIES OF  Fc  RECEPTOR-BEARING T  CELLS 
with D. H.'s lymphocytes were essentially identical to those presented for L. G.'s 
lymphocytes (not shown). 
PBL obtained from L. G. and D. H. were analyzed by two-color immunofluo- 
rescence  using PE-conjugated  anti-Leu-1 lc/B73.1  and a  panel  of FITC-conju- 
gated  antibodies  against  other  T  cell-  and  NK  cell-associated  differentiation 
antigens. The results using L. G.'s lymphocytes are presented in Fig. 4. As shown 
in  Figs.  1-3,  two distinct populations of CD16 + (Leu-1 lc +) lymphocytes  could 
be identified based on the amount of CD16 antigen present on the cell surface. 
The majority of dim CD 16 + cells coexpressed the pan-T cell-associated antigens 
CD3 (Leu-4) and CD5 (Leu-1).  In contrast,  the bright CD 16 + cells lacked these 
pan-T  cell  antigens.  However,  as shown  in  the  lower  left  panel,  CD8  (Leu-2) 
antigen was apparently expressed in low amounts on a small proportion of both 
the  dim  and  bright  CD16 +  lymphocytes.  Expression  of low  amounts  of CD8 
antigen on a minor proportion of CD 16 + lymphocytes has been reported previ- 
ously (8).  CD4  (Leu-3)  was  not  coexpressed  on  CD16 +  lymphocytes  (Fig.  4), 
indicating  that  most  CD16 +  lymphocytes  (both  dim  and  bright  subsets)  lack 
expression  of either  the  CD4  or CD8 antigen.  Furthermore,  HLA-DR,  CD19 
(Leu-12), IL-2-R, and Leu-M3 also were not coexpressed on CD16 + lymphocytes 
(not shown). A subset of CD16 + cells coexpressed the Leu-7 antigen (Fig. 4), and 
a  majority of CD16 + lymphocytes (both dim and bright CD16 +) were found to 
coexpress the CR3 (Leu-15) and CD2 (Leu-5) antigens (not shown). Qualitatively, 
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FIGURE 4.  Coexpression  of T  cell-associated  antigens on  CD16 + lymphocytes.  Peripheral 
blood mononuclear cells (L. G.) were stained with: FITC-IgG and PE-IgG control antibodies; 
F1TC-anti-Leu-4 and PE-anti-Leu-11 c/B73.1 ; FITC-anti-Leu-1 and PE-anti-Leu-11 c/B73.1 ; 
FITC-anti-Leu-2a  and  PE-anti-Leu-llc/B73.1;  FITC-anti-Leu-3a  and  PE-anti-Leu- 
1 lc/B73.1;  and  FITC-anti-Leu-7 and  PE-anti-Leu-1 lc/B73.1.  Data  are  presented  as  de- 
scribed in Fig,  1.  Quantitation of the data revealed:  10,6% CD3 + (Leu-4+), CD16+;  11.1% 
CD5 ÷ (Leu-I +), CD16+; 6.3% CD8 + (Leu-2+), CD16+; <1% CD4  + (Leu-3+), CDI6+; and 13.3% 
Leu-7+,CDI6  + lympbocytes.  >98%  of lymphocytes were in  quadrant III  (unstained) in  the 
control sample. LANIER  ET  AL.  2095 
essentially  identical  profiles  were  observed  when  D.  H.'s  lymphocytes  were 
examined using this panel of reagents (not shown). 
PBL from 46 normal,  random blood donors were examined for coexpression 
of the CD3 and CD 16 surface antigens.  Most individuals examined (40/46) had 
low (<2%) to undetectable levels of circulating CD3+,CD 16  + cells. Six individuals 
expressed >2% CD3+,CD16 + lympbocytes. In three of these six individuals, the 
CD3+,CD16 + cells  comprised  2-5%  of lymphocytes.  Only  lymphocytes from 
three individuals, including D. H. and L. G., contained >5% CD3+,CD16 + cells. 
In all cases observed, the amount of CD16 antigen expressed on the CD3 + T  cell 
subset was significantly less than on the CD3- NK cell population. 
L. G.'s parents were analyzed and found to have <1% CD3+,CD16 + lympho- 
cytes. The  families of two other  individuals  (caucasians  of european  ancestry) 
who  demonstrated  significantly  higher  proportions  of  these  cells  were  also 
examined (Table I). Most family members had <1% CD3+,CD16 + lymphocytes 
(pedigree charts given in Fig. 5). 
Cytolytic Activity of CD3+,CD16 + and CD3-,CD16 + Lymphocytes.  Lymphocytes 
from  D.  H.  were  stained  with  FITC-anti-Leu-1 la  and  PE-anti-Leu-4  (CD3). 
The CD3-,CD 16  + and CD3÷,CD 16  + cells were isolated by two-color cell sorting. 
Reanalysis of the purified subpopulations indicated >95% purity.  As shown in 
Fig.  6,  CD3+,CD16 + cells were mononuclear  lymphocytes with  distinct  azuro- 
philic  granules.  The  cells  were  tested  for  cytotoxic activity  against  the  NK- 
sensitive  tumor  cell  line  K562  immediately  after  isolation  and  after  1  wk  of 
culture in IL-2 (Fig. 7). The CD3-,CD16 + NK cells mediated cytolysis of K562, 
which was augmented by IL-2 treatment.  Additionally,  IL-2 activation enabled 
TABLE  I 
Coexpression of CD3 and CD16: Normal Donors and Family Studies 
Individuals tested 
Phenotype (percent of lymphocytes) 
CD3-,CD16  ÷  CD3÷,CD16 +  CD3÷,CD16 - 
Family 1 
1  8  7  77 
2  7  <1  84 
3  5  <1  86 
4  3  3  86 
5  5  <1  86 
Family 2 
1  7  3  77 
2  6  1  81 
3  2  4  82 
4  4  3  86 
5  4  1  83 
6  5  <l  83 
7  3  1  82 
8  7  1  81 
Peripheral blood mononuclear cells were stained with FITC anti-Leu-1 la 
and Texas  Red-avidin/biotin anti-Leu-4, or appropriate fluorochrome- 
conjugated Ig controls. Based on the control sample, the percentage of 
lymphocytes with the indicated antigenic phenotype was determined. 
FIGURE 5.  Pedigree charts of 
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FIGURE 6.  Morphology. CD3+,CD  16- T cells (A); CD3+,CD  16  ÷  T cells  (B);  and CD3-,CD 16  ÷ 
NK cells (C), isolated as described in Fig. 7, were cytocentrifuged onto glass slides and stained 
with Giemsa. Magnification, × 5,500. 
the  CD3-,CD16 + cells to  lyse  the  relatively NK-insensitive  CCRF-SB  cell  line 
(Fig.  7). The CD3+,CD16 + cells showed little cytolytic activity, either before or 
after IL-2 treatment (Fig.  7).  Comparison of the cytotoxicity of unstained cells 
and cells stained with anti-Leu-4 or anti-Leu-11  indicated that these antibodies 
did not inhibit activity. K562 lysis was slightly increased in the anti-Leu-4-stained 
cells compared to unstained cells (not shown). 
We were  unable  to directly access the ADCC  activity of the freshly isolated 
CD3+,CD16 + and CD3-,CD16 + cells, since the anti-Leu-11  antibody efficiently 
inhibits ADCC function (12,  13). However, to determine whether ADCC activity 
was present in D.  H.'s T  cell population, nonadherent peripheral blood mono- 
nuclear cells were stained with  FITC-anti-Leu-1  (CD5) antibody, and the cells 
were separated  into CD5- and  CD5 + subpopulations  using a  fluorescence-acti- 
vated  cell  sorter  (FACS).  As  shown  in  Fig.  8,  significant  ADCC  activity  was 
detected  in  both  the  CD5 + and  CD5-  populations.  Furthermore,  addition  of 
anti-Leu-11  antibody to the assay completely inhibited the ADCC  mediated by LANIER  ET  AL.  2097 
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FIGURE 7.  NK cell activity of CD3+,CDI6  ÷ and CD3-,CD16  + lymphocytes. Nonadherent 
PBL (D. H.), depleted of B cells using a nylon wool column, were stained with FITC-anti- 
Leu-1 la and PE-anti-Leu-4. The CD3  + ,CDI6  ÷ and CD3-,CD16  + cells were separated using 
the FACS. Reanalysis of the separated subpopulations indicated >95% purity. Morphological 
examination revealed that >99% of the sorted cells were lymphocytes.  The sorted subpopu- 
lations and  stained, unsorted  lymphocytes were tested  for cytotoxic activity against 5tCr- 
labelled K562 tumor cells in a  4-h radioisotope-release assay (A). The CD3+,CDI6  + and 
CD3-,CD16  + cells were placed in culture medium containing purified IL-2, and again tested 
for cytotoxic activity against K562 and CCRF-SB tumor cells after  1 wk (B). Analysis of the 
antigenic phenotypes after 1 wk in culture indicated that the CD3-,CD164 and CD3+,CDI64 
populations contained -98% CD3-,CD164 and  CD3+,CD164 cells, respectively. 2% of the 
cells in the CD3+,CD164 culture were CD3-,CD16  + cells. By extrapolation of the effector/ 
target (E/T) curves, this small contamination of activated CD3-,CD 164 NK cells may account 
for the low levels of cytotoxicity observed against K562 in the CD3+,CD  164 population. 
both the  CD5- and CD5  + subsets.  In contrast,  antibody against CR3  (Leu-15), 
an antigen  present  on both the  CD3÷,CD16  -  and  CD3+,CD16  ÷ cells,  failed to 
affect ADCC activity. By direct two-color immunofluorescence analysis, ~21.4% 
of the  CD5  ÷ T  lymphocytes coexpressed  CD16,  whereas  63.4%  of the  CD5- 
lymphocytes were  CD16  ÷ NK cells.  These data suggest that a  CD16-associated 
FcR was involved in the ADCC mediated by both populations. 
Proliferation of CD3+,CD16 + Lymphocytes  Cocultured with Allogeneic Tumor Cell 
Lines.  The CD3+,CD 16 ÷ and CD3-,CD 16  + cells were cocultured with irradiated 
NK-sensitive  K562 tumor cells,  irradiated  NK-insensitive CCRF-SB B  lympho- 
blastoid cells, or purified IL-2 for 6 d.  As shown in Table II, CD3-,CD16  + cells 
proliferated vigorously in response to K562 and IL-2, but less well in response 
to  CCRF-SB.  Consistent  with  our  previous  findings  (32),  the  response  of the 
CD3-,CD16  + NK cells was only partially inhibited  (~20%)  by the  presence of 
anti-IL-2-R (TAC) antibody in the culture.  In contrast, the CD3÷,CD16  ÷ popu- 
lation was strongly stimulated by both K562 and CCRF-SB. Furthermore, anti- 
IL-2R antibodies inhibited the response against CCRF-SB by 75%, compared to 
only  25%  against  K562.  The  proliferative  response  by the  CD3+,CD16  ÷ cells 
cultured in IL-2 similarly was greatly inhibited (89%) by the presence of anti-IL- 
2-R antibody. 
Culture ofCD3+,CD16 + Lymphocytes.  CD3+,CD16  ÷ and CD3-,CD16  + lympho- 
cytes were placed into culture and maintained as IL-2-dependent cell lines. The 
CD3+,CD16  + cells  had  a  24-48-h  generation  time,  whereas  the  CD3-,CD16  + 2098  FUNCTIONAL  PROPERTIES  OF  Fc  RECEPTOR-BEARING  T  CELLS 
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FIGtm~ 8.  ADCC activity of CD5- and CD5  ÷ lymphocytes and  inhibition by anti-Leu-11 
antibody. Nonadherent  peripheral  blood mononuclear cells from D. H.  were stained with 
FITC-anti-Leu-1 (CD5) and separated into CD5 ÷ and CD5- subsets using a FACS. Reanalysis 
indicated 98% purity. A: CD5- and CD5  ÷ lymphocytes were tested for ADCC activity against 
5~Cr-labelledJY tumor cells  preincuhated with an IgG2a anti-HLA mAb, ME1. No cytotoxicity 
was observed against JY cells not preincubated with antibody. B: Anti-Leu-11 or anti-Leu-15 
mAb were added to the ADCC assay at 5 ug/ml. JY target cells do not express the CD 16 (Leu- 
11) or CRs (Leu-15) antigens. 
cells grew more slowly. The growth of these cells was dependent on the presence 
of IL-2.  After 3  wk  in culture, these cells were assayed for ADCC activity and 
NK  cell-mediated cytotoxicity against  the JY  lymphoblastoid B  cell line.  IL-2 
cultured CD3-,CD16 + NK cells demonstrated high levels of cytotoxicity against 
JY in the absence of antibody (Fig. 9). This is consistent with prior observations 
(32) that CD16 + NK cells can lyse both NK-sensitive and NK-insensitive targets 
after activation with IL-2. The high background of NK activity against JY in the 
absence of antibody (78% specific iysis at an effector/target ratio of 4:1) obscured 
any ADCC  activity. In contrast,  CD3+,CD16 + cells mediated only low levels of 
JY cytotoxicity in the absence of antibody. Using an IgG2a switch-variant of the 
anti-HLA mAb MA2.1, we observed significant ADCC activity. The parent IgG 1 
MA2.1 antibody, however, failed to cause any increase inJY cytolysis. The IgG2b 
switch-variant of MA2.1  directed only a  modest increase in cytotoxicity. 
Phenotypic analysis of the CD3+,CD16 + ceils after 3  wk in culture indicated 
that  ~95%  retained  the  CD3  and  CD16  antigens.  The amount  of CD16  and 
CD3  antigen on these cells after short-term culture in  IL-2 was approximately 
the same as present on the freshly isolated lymphocytes. Furthermore, the cells 
expressed IL-2-R (40%), HLA-DR antigens (95%), CD2 (83%), and CD5 (95%). 
As with the freshly isolated cells (Fig. 3), the majority of the cultured cells (~80%) 
expressed neither the CD4 nor CD8 antigens. That CD3+,CD16 + cells expressed LANIER  ET  AL. 
TABLE  II 
Alloantigen and IL-2 Stimulation of CD3+,CD16 + Lymphocytes 
2099 
Responder 
[3H]Thymidine  Percent 
inhibition  Stimulator  Antibody  incorporation  SI  with anti- 
(cpm +_ SD)  body 
Control PBL 
D. H. PBL 
CD3-,CD16  + (D. H.) 
CD3+,CD16 ÷ (D. H.) 
None  None  6,790 --- 230  --  -- 
IL-2  Control  81,640 4- 310  14.1  -- 
IL-2  Anti-IL-2-R  35,898 4- 620  6.2  56 
K562  Control  136,644 4- 740  23.6  -- 
K563  Anti-IL-2-R  105,378 4- 1,120  18.2  22 
CCRF-SB  Control  160,962 -  1,260  27.8  -- 
CCRF-SB  Anti-IL-2-R  55,005 -  891  9.5  65 
None  None  7,600 -4- 820  --  -- 
IL-2  Control  89,680 4- 360  11.5  -- 
IL-2  Anti-IL-2-R  45,600 +  420  6.0  48 
K562  Control  123,880 +- 1,160  16.3  -- 
K562  Anti-IL-2-R  75,520 -+ 1,000  10.2  37 
CCRF-SB  Control  209,000 -+ 1,421  27.5  -- 
CCRF-SB  Anti-IL-2-R  99,560 +  680  13.1  52 
None  None  230 _  160  --  -- 
IL-2  Control  8,809 4- 165  38.3  -- 
IL-2  Anti-IL-2-R  6,785 _+ 220  29.5  22 
K562  Control  21,919 4- 631  95.3  -- 
K562  Anti-IL-2-R  17,296 4- 412  75.2  21 
CCRF-SB  Control  1,886 4- 206  8.2  -- 
CCRF°SB  Anti-IL-2-R  1,081  --- 151  4.7  42 
None  None  294 +  110  --  -- 
IL-2  Control  7,908 +  375  26.9  -- 
IL-2  Anti-IL-2-R  823 +  120  2.8  89 
K562  Control  28,224 4- 410  96.0  -- 
K562  Anti-IL-2-R  21,109 4- 593  71.8  25 
CCRF-SB  Control  11,789 -+ 295  40.1  -- 
CCRF-SB  Anti-IL-2-R  2,881  +  173  9.8  75 
CD3+,CD16 + and  CD3-,CD16 ÷  lymphocytes from  D.  H.  were  isolated as  described in  Fig.  7. 
CD3+,CD16+;  CD3-,CD16+; and unseparated PBL from D.  H. and a  random, normal donor were 
cocultured with purified IL-2 (10% vol/vol) or with mitomycin C-treated K562 or CCRF-SB cells at 
a responder/stimulator  ratio of 1  : 1. Anti-IL°2-R or an isotype-matched  control Ig were added to the 
indicated cultures at a  final concentration of 100  #g/ml.  After 5  d, wells were pulsed with [SH]- 
thymidine and harvested. The mean cpm _  SD of triplicate wells are presented. The stimulation 
index (SI) was calculated as: (mean cpm stimulated cultures)/(mean cpm unstimulated culture). 
functional  FcR  was confirmed  by their ability to specifically bind  dimeric  rabbit 
IgG. This  binding  was completely  inhibited  by anti-Leu-1 1  mAb. 
Anti-CD3  Directs  Non-antigen-specific  Cytotoxicity  by  CD3+,CD16 +  Cells. 
Recently  (33,  34)  it has been  reported  that  antigen-specific, major  histocompat- 
ibility complex  (MHC)-restricted  cytotoxic  CD3 + T  cell clones may kill  inappro- 
priate  target  cells in  the  presence  of anti-CD3  antibodies.  As shown  in  Fig.  10, 
cultured  CD3+,CD16  + cells kill the relatively NK-insensitive JY and  LCL  207  B 
lymphoblastoid  cell lines in the presence  of anti-Leu-4  (CD3). Because the targets 2100  FUNCTIONAL  PROPERTIES  OF  Fc  RECEPTOR-BEARING  T  CELLS 
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FmURE  9.  ADCC activity of CD3+,CD16 ÷ lymphocytes. After 3 wk culture in IL-2-contain- 
ing medium, CD3-,CD16÷and  CD3÷,CD16  ÷ lymphocytes were tested for NK cell-mediated 
cytotoxicity against the JY B lymphoblastoid cell line in a  4-h radioisotope-release assay  (A). 
In B, the ADCC activity of the CD3+,CD 16 ÷ cells was tested in a 4-h radioisotope-release assay 
using 5~Cr-labelled JY cells preincubated with isotype switch-variants of the MA2.1 (anti-HLA- 
A2-specific) mAb. 
do not express CD3, this cytotoxicity was induced by the interaction of anti-CD3 
with the effector cells. As demonstrated elsewhere  2 (35), the cytolytic activity of 
CD3-,CD16 + NK cells was unaffected by anti-CD3 mAb. 
The role of class  I MHC molecules in the anti-CD3-induced cytotoxicity was 
examined using Daudi as a  target cell line.  Although Daudi does not express 
class I  MHC  molecules, these B  lymphoblastoid cells were lysed efficiently by 
CD3+,CD16 + cells, but only in the presence of anti-Leu-4 (CD3) antibody (Fig. 
10). Unlike anti-Leu-4, the addition of anti-Leu-11 antibody to the cultures failed 
to induce cytotoxicity against Daudi (Fig.  10). 
Discussion 
In most individuals, cells with the phenotype CD3+,CD16 + comprise <2% of 
total  PBL  (8-10,  12,  30,  31).  However,  we  have  recently identified several 
healthy individuals who possess significant levels of these cells in their peripheral 
blood.  In  this  study,  we  have  examined  the  antigenic,  morphological,  and 
functional properties of this unique subset of T  iymphocytes. 
FcR for IgG are expressed on two distinct populations of human lymphocytes. 
The majority of these FcR  + lymphocytes lack the CD3  antigen, and mediated 
NK cell-mediated cytotoxicity (5-7).  Expression of IgG FcR on a  very minor 
subpopulation of CD3 + T  lymphocytes has been previously identified (5-7,  23) 
using either EA rosette procedures or dimeric rabbit IgG complexes. However, 
due to the low levels of these cells in most individuals, and the technical difficulties 
involved in efficiently separating the CD3+,FcR  + and CD3-,FcR + subsets, there 
2 Phillips, J. H., and L. L. Lanier.  1985. Lectin-dependent and anti-CD3-induced cytotoxicity are 
mediated by peripheral blood cytotoxic T  lymphocytes expressing the Leu-7 antigen.  Manuscript 
submitted for publication. LANIER ET  AL. 
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FIGURE 10.  Anti-CD3-induced cytotoxicity mediated by CD3+,CD16  ÷ lymphocytes. After 3 
wk in culture in I  L-2-eontaining  medium, CD3÷,CD  16  ÷ lymphocytes  were tested for cytotoxic 
activity against the JY, Daudi, and LCL 207 B cell lines in the presence or absence of anti- 
Leu-4 mAb (4 ~g/ml) or anti-Leu-11 mAb (4 gg/ml; Daudi experiment). 
have been few functional studies comparing these populations.  Furthermore, it 
has been unclear whether or not FcR present on CD3 + T  lymphocytes would be 
recognized by anti-Leu-11 and similar antibodies that react with the FcR present 
on CD3- NK cells and granulocytes. In our experiments, we have shown that, in 
certain individuals, a  subset of T  cells can express  the  FcR recognized by the 
anti-Leu-11  antibody, and that these CD3+,CD16 + T  cells can mediate ADCC 
via this FcR. Consistent with these cells being within the T  cell lineage, we have 
shown  that  essentially  all  of  the  CD3+,CD16 ÷  lymphocytes  coexpress  CD2 
(E rosette  receptor)  and  CD5  (Leu-1) antigens.  Furthermore,  anti-Leu-4 anti- 
body immunoprecipitates a  22-29  kD protein complex from the cell surface of 
these  CD3÷,CD16 +  lymphocytes,  similar  to  the  CD3  antigen  isolated  from 
CD3+,CD16 -  T  lymphocytes (our  unpublished  observation).  It  is  unresolved 
whether the CD3÷,CD16 + cells represent a monoclonal or polyclonal population 
of T  lymphocytes. Since it is possible to culture these cells in IL-2, we may be 
able to examine this question in future studies. 
These CD3+,CD16 + tymphocytes are different than typical T  ceils in several 
aspects. Unlike resting T  lymphocytes, CD3÷,CD 16 + have numerous azurophilic 
granules,  similar to  NK  cells and  in  vitro-activated cytotoxic T  lymphocytes. 
Furthermore, unlike most T  lymphocytes CD3+,CD16 ÷ lymphocytes lack detect- 
able surface expression of either CD4 or CD8. Since these antigens are implicated 
(36-38) in cell-cell interactions involving class II and class I antigens, respectively, 
failure to express CD4 and CD8 suggests that CD3+,CD 16 ÷ cell may not require 
MHC  gene  products  for  target  cell  recognition.  CD3+,CD16 ÷ cells  were  also 
distinct in that they expressed approximately twice the level of CD3 as CD16- T 
lymphocytes,  and  expressed  lower  levels  of  CD5  than  most  other  T  cells. 2102  FUNCTIONAL  PROPERTIES  OF  Fc  RECEPTOR-BEARING  T  CELLS 
Furthermore,  this subset expressed approximately one-tenth the level of CD16 
found on  the CD3-,CD16 + NK cells.  This  is corroborated by the low level of 
binding observed when these cells were stained with FITC-labeled dimeric rabbit 
IgG. Due to the low levels of FcR expression, the frequency of this cell population 
may  have  been  underestimated  in  many  studies.  Unless  immunofluorescent 
reagents and immunofluorescence detection systems are optimized, this popula- 
tion may be undetectable. 
This CD3+,CD 16 + population lacked NK activity. However, these cells could 
be rendered  cytotoxic by two mechanisms.  The  CD3+,CD16 + cells efficiently 
mediated ADCC activity against antibody-coated targets. These cells may mediate 
a similar function in vivo, thereby providing a cytotoxic T  lymphocyte with the 
capacity to  recognize  and  lyse an  antibody-coated target  through  a  structure 
distinct from the T  cell antigen receptor. Although there have been reports (15, 
16) that T  cells isolated from patients with certain lymphoproliferative disorders 
can mediate ADCC, but not NK activity, the isolation of this T  cell subset from 
the peripheral  blood of a normal,  healthy individual  has not been reported.  As 
previously demonstrated  for  CD3-,CD16 + NK  cells (13),  the  CD3+,CD16 + T 
cells preferentially mediate ADCC with IgG2a antibodies. IgG2b antibodies were 
less efficient, whereas IgG1  antibodies demonstrated no significant cytotoxicity. 
These  data  suggest  that  the  FcR  on  these  CD3 +  T  cells  is  functionally  and 
antigenically  quite  similar  to  the  FcR  present  on  CD3-  NK  cells.  However, 
further comparative studies on the biochemical structure of these receptors will 
be required to address this issue. 
CD3+,CD16 + lymphocytes were also rendered  cytotoxic against  several NK- 
resistant B lymphoblastoid cell lines when anti-Leu-4 (CD3) antibody was present 
in  the  assay.  Recently,  several  investigators  (33,  34)  have  demonstrated  that 
antigen specific cytotoxic T  cells can nonspecifically lyse tumor cell targets in the 
presence of anti-CD3 mAb. Since the CD3 antigen is structurally associated with 
the T cell antigen receptor heterodimer (39-43), anti-CD3 antibodies may induce 
cytotoxic activity in cytotoxic T  lymphocytes by antigenic mimicry. Although the 
antigenic specificity of the CD3+,CD16 + population  is unknown,  we show here 
that  anti-CD3  can  induce  significant  cytotoxic activity.  The  anti-CD3-induced 
cytotoxicity does not require recognition of class I MHC antigens on the target, 
since the CD3+,CD 16  + cells lysed Daudi efficiently. 
Since CD3+,CD16 + can  mediate  both ADCC and  nonspecific cytotoxicity in 
the presence of anti-CD3 antibodies, it is possible that the two mechanisms may 
be related.  Binding  to the  FcR may perturb  the CD3-T cell antigen  receptor 
complex, thus stimulating  cytotoxic activity.  Contrary  to this  hypothesis, how- 
ever, is our observation that  soluble anti-Leu-11  antibody did not induce cyto- 
toxicity in the CD3+,CD16 + population.  Whether anti-Leu-11  complexed to an 
insoluble matrix may activate these cells remains to be determined. 
The  proliferative  response  of the  CD3+,CD16 +  population  shares  certain 
features with both typical T  lymphocytes and NK cells. We have shown that NK 
cells (CD3-,CD16 +)  proliferate  vigorously when  cocultured  with  NK-sensitive 
K562  tumor  cells,  and  that  they  proliferate  poorly  when  cultured  with  a  B 
lymphoblastoid  cell  line,  CCRF-SB  (30).  In  contrast,  T  lymphocytes 
(CD3+,CD 16-) are stimulated preferentially by CCRF-SB. Furthermore, the two LANIER  ET  AL.  2103 
cell types were functionally distinguished in that the T  cell response, but not the 
NK cell response,  could be significantly inhibited by anti-IL-2-R antibody (30). 
In  this  study,  the  CD3+,CD16 + population  was  stimulated  by coculture  with 
either  K562  or  CCRF-SB.  The  response  against  CCRF-SB  was  much  more 
sensitive to inhibition  by anti-IL-2-R antibody than  the response against K562. 
It is unlikely that the strong response against K562 was due to contamination by 
NK cells, since reanalysis of the isolated population showed <1%  CD3-,CD16 + 
cells. It is possible that the CD3+,CD 16  + population is heterogeneous, with some 
cells responding to K562 and others to CCRF-SB. Alternatively, each cell may 
possess  two  distinct  mechanisms  for  activation,  one  of which  is  resistant  to 
inhibition by anti-IL-2-R antibody. 
The origin and relationship  of CD3+,CD16 + T  cells to FcR- T  cells are not 
known.  In  previous  studies  we  did  not  observe  induction  of CD16  antigen 
expression  on  T  lymphocytes  upon  activation  with  mitogens  or  alioantigens. 
Furthermore,  after 3 wk of culture in IL-2, CD3+,CD16 + cells retained expres- 
sion of both the CD3 and CD16 antigens. Stable surface expression of CD16 on 
these CD3+,CD16 + cytotoxic T  cells in both D. H. and L. G.'s peripheral  blood 
was found over an observation period of 18 and 6 mo, respectively. This indicates 
that these cells are not present as a consequence of acute infection. Furthermore, 
both L. G. (female) and D. H. (male) are healthy individuals (25-35 y old) with 
no known illness. It may be noteworthy that these individuals are both oriental, 
since Prince et al. (44) reported the level of CD 16 ÷ lymphocytes to be significantly 
elevated  in  certain  Chinese  individuals.  However,  a  limited  study  of other 
Chinese  individuals  did  not  reveal  many  to  have  high  levels  of circulating 
CD3+,CD16 + lymphocytes (L. Lanier and H. Prince,  unpublished observation). 
Family studies described here demonstrate relatively high proportions of circu- 
lating CD3+,CD16 + cells in persons of other ethnic backgrounds.  The distribu- 
tion of CD3+,CD16 + cells within these families suggests genetic mechanisms may 
operate to influence the proportion  of these cells in peripheral  blood. Further 
studies are required to test this hypothesis. 
Summary 
A  subset of peripheral  blood T  lymphocytes coexpressing CD3  and  IgG Fc 
receptors  (FcR)  (CD16/Leu-ll  antigen)  have  been  identified,  isolated,  and 
functionally  characterized.  The  CD3÷,CD16  +  cells  were  established  in  short- 
term  culture  using  growth  medium  containing  interleukin  2  (IL-2).  Both  the 
freshly isolated cells and the cultured cell line stably expressed the CD3÷,CD16 + 
phenotype. Furthermore,  a majority of these T  cells lacked either CD4 or CD8 
expression.  Like in  vitro-activated  cytotoxic T  iymphocytes and  natural  killer 
(NK) cells,  the  CD3+,CD16 + cells showed numerous  azurophilic  granules.  Al- 
though  these  ceils  failed  to  mediate  significant  levels  of  NK  cell-mediated 
cytotoxicity  even  after  stimulation  with  IL-2,  they  efficiently  functioned  as 
effectors of antibody-dependent  cellular  cytotoxicity (ADCC).  The  Ig  isotype 
specificity of the ADCC was analyzed using an isotype switch-variant family of a 
murine anti-HLA monoclonal antibody (mAb). Similar to the CD3-,CD16 + NK 
cell population, the CD3+,CD16 + T  cells preferentially used the IgG2a antibody 
to mediate ADCC. The CD3÷,CD 16  + cells demonstrated a proliferative response 2104  FUNCTIONAL  PROPERTIES OF  Fc  RECEPTOR-BEARING T  CELLS 
when cocultured with either  a  NK-sensitive tumor cell  line,  K562,  or  a  NK- 
insensitive B lymphoblastoid cell line, CCRF-SB. The response against CCRF-SB 
was significantly inhibited by anti-IL-2 receptor antibody, whereas the response 
against K562 was only partially diminished. Cytotoxicity was also induced in the 
CD3+,CD16 +  population  by  the  presence  of anti-CD3  mAb,  indicating  that 
cytotoxicity can be triggered by stimulation via the CD3-T cell antigen receptor 
complex.  By isolating these  CD3+,CD16 ÷ cells from the peripheral  blood of a 
normal,  healthy individual,  it has been  possible  to extensively study the  mor- 
phology, antigenic phenotype, and functional behavior of this unique subset of 
T  lymphocytes expressing IgG FcR. 
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